(Q53554571)

15 May 2018

title

Serum M-spike and transplant outcome in patients with multiple myeloma. (English)

1 reference

15 May 2018

author

Jorge M. Pacheco

2

1 reference

15 May 2018

Angela Dispenzieri

3

1 reference

15 May 2018

David Dingli

1

David Dingli

1 reference

15 May 2018

6

Martha Q Lacy

1 reference

15 May 2018

8

Morie A Gertz

1 reference

15 May 2018

Suzanne R Hayman

4

Suzanne R Hayman

1 reference

15 May 2018

Shaji K Kumar

5

Shaji K Kumar

1 reference

15 May 2018

Dennis A Gastineau

7

Dennis A Gastineau

1 reference

15 May 2018

publication date

4 May 2007

1 reference

15 May 2018

published in

Cancer Science

1 reference

15 May 2018

volume

98

1 reference

15 May 2018

issue

7

1 reference

15 May 2018

page(s)

1035-1040

1 reference

15 May 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

VAD-based regimens as primary treatment for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Cellular Kinetics, Staging, and Immunoglobulin Synthesis in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

International staging system for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Plasma volume nomograms for use in therapeutic plasma exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Cellular kinetics in multiple myeloma. A new approach to staging and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Molecular pathogenesis and a consequent classification of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in southwest oncology group chemotherapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

The pharmacologic basis of high dose chemotherapy with haematopoietic stem cell support for solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Single versus double autologous stem-cell transplantation for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Physiology: Why does metabolic rate scale with body size?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Combining Gompertzian growth and cell population dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

A general model for ontogenetic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Elimination mechanisms of therapeutic monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

Impact of complete remission with intensive therapy in patients with responsive multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00499.X

10.1111/J.1349-7006.2007.00499.X

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018